Real‑World Evidence as Part of Post‑Approval Commitments
Real‑World Evidence as Part of Post‑Approval Commitments Leveraging Real‑World Evidence to Fulfill Post‑Approval Regulatory Commitments Understanding the Role of RWE Post‑Approval After a drug or biologic gains regulatory approval, its journey is far from over. Regulators often impose post‑approval commitments—studies designed to confirm long-term safety, effectiveness, and risk mitigation strategies in the real-world population. While…
Read More “Real‑World Evidence as Part of Post‑Approval Commitments” »